These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 20534479)

  • 1. Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion.
    Grugan KD; Miller CG; Yao Y; Michaylira CZ; Ohashi S; Klein-Szanto AJ; Diehl JA; Herlyn M; Han M; Nakagawa H; Rustgi AK
    Proc Natl Acad Sci U S A; 2010 Jun; 107(24):11026-31. PubMed ID: 20534479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A common p53 mutation (R175H) activates c-Met receptor tyrosine kinase to enhance tumor cell invasion.
    Grugan KD; Vega ME; Wong GS; Diehl JA; Bass AJ; Wong KK; Nakagawa H; Rustgi AK
    Cancer Biol Ther; 2013 Sep; 14(9):853-9. PubMed ID: 23792586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma.
    Saito S; Morishima K; Ui T; Hoshino H; Matsubara D; Ishikawa S; Aburatani H; Fukayama M; Hosoya Y; Sata N; Lefor AK; Yasuda Y; Niki T
    BMC Cancer; 2015 Feb; 15():82. PubMed ID: 25884729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation.
    Okawa T; Michaylira CZ; Kalabis J; Stairs DB; Nakagawa H; Andl CD; Johnstone CN; Klein-Szanto AJ; El-Deiry WS; Cukierman E; Herlyn M; Rustgi AK
    Genes Dev; 2007 Nov; 21(21):2788-803. PubMed ID: 17974918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of HGF/c-met system in invasion and metastasis of oral squamous cell carcinoma cells in vitro and its clinical significance.
    Uchida D; Kawamata H; Omotehara F; Nakashiro Ki ; Kimura-Yanagawa T; Hino S; Begum NM; Hoque MO; Yoshida H; Sato M; Fujimori T
    Int J Cancer; 2001 Aug; 93(4):489-96. PubMed ID: 11477552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Met in esophageal squamous cell carcinoma: an independent prognostic factor and potential therapeutic target.
    Ozawa Y; Nakamura Y; Fujishima F; Felizola SJ; Takeda K; Okamoto H; Ito K; Ishida H; Konno T; Kamei T; Miyata G; Ohuchi N; Sasano H
    BMC Cancer; 2015 Jun; 15():451. PubMed ID: 26036285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
    Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
    Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
    Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
    J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas.
    Ren Y; Cao B; Law S; Xie Y; Lee PY; Cheung L; Chen Y; Huang X; Chan HM; Zhao P; Luk J; Vande Woude G; Wong J
    Clin Cancer Res; 2005 Sep; 11(17):6190-7. PubMed ID: 16144920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.
    Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
    Mol Cancer Res; 2008 Oct; 6(10):1521-33. PubMed ID: 18922968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary human fibroblasts induce diverse tumor invasiveness: involvement of HGF as an important paracrine factor.
    Iwazawa T; Shiozaki H; Doki Y; Inoue M; Tamura S; Matsui S; Monden T; Matsumoto K; Nakamura T; Monden M
    Jpn J Cancer Res; 1996 Nov; 87(11):1134-42. PubMed ID: 9045942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma.
    Tian B; Chen X; Zhang H; Li X; Wang J; Han W; Zhang LY; Fu L; Li Y; Nie C; Zhao Y; Tan X; Wang H; Guan XY; Hong A
    Oncotarget; 2017 Jun; 8(26):42300-42313. PubMed ID: 28404945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma.
    Kato H; Arao T; Matsumoto K; Fujita Y; Kimura H; Hayashi H; Nishiki K; Iwama M; Shiraishi O; Yasuda A; Shinkai M; Imano M; Imamoto H; Yasuda T; Okuno K; Shiozaki H; Nishio K
    Int J Oncol; 2013 Apr; 42(4):1151-8. PubMed ID: 23426935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of SRC-3 promotes esophageal squamous cell carcinoma aggressiveness by enhancing cell growth and invasiveness.
    Xu FP; Liu YH; Luo XL; Zhang F; Zhou HY; Ge Y; Liu C; Chen J; Luo DL; Yan LX; Mei P; Xu J; Zhuang HG
    Cancer Med; 2016 Dec; 5(12):3500-3511. PubMed ID: 27781415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression.
    Jiang S; Zhao C; Yang X; Li X; Pan Q; Huang H; Wen X; Shan H; Li Q; Du Y; Zhao Y
    Int J Mol Med; 2016 Jul; 38(1):113-22. PubMed ID: 27247259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esophageal squamous cell carcinoma invasion is inhibited by Activin A in ACVRIB-positive cells.
    Loomans HA; Arnold SA; Quast LL; Andl CD
    BMC Cancer; 2016 Nov; 16(1):873. PubMed ID: 27829391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of transforming growth factor-β signaling potentiates tumor cell invasion into collagen matrix induced by fibroblast-derived hepatocyte growth factor.
    Oyanagi J; Kojima N; Sato H; Higashi S; Kikuchi K; Sakai K; Matsumoto K; Miyazaki K
    Exp Cell Res; 2014 Aug; 326(2):267-79. PubMed ID: 24780821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion.
    Murai M; Shen X; Huang L; Carpenter WM; Lin CS; Silverman S; Regezi J; Kramer RH
    Int J Oncol; 2004 Oct; 25(4):831-40. PubMed ID: 15375530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic stellate cell promoted hepatoma cell invasion via the HGF/c-Met signaling pathway regulated by p53.
    Liu WT; Jing YY; Yu GF; Chen H; Han ZP; Yu DD; Fan QM; Ye F; Li R; Gao L; Zhao QD; Wu MC; Wei LX
    Cell Cycle; 2016; 15(7):886-94. PubMed ID: 27077227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3β/Snail signaling pathway.
    Shan B; Man H; Liu J; Wang L; Zhu T; Ma M; Xv Z; Chen X; Yang X; Li P
    Oncol Rep; 2016 Sep; 36(3):1551-61. PubMed ID: 27430162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.